14 December 2017: ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, is pleased to announce its interim results for the six months ended 30 September 2017.
To view the Interim Results Presentation slide deck please click here.
To log on to view the webcast of the analyst presentation please click here.